Feature | August 15, 2012 | Dave Fornell

TAVR, EVAR Vascular Closure Device May Eliminate Need for Surgical Cut-Down

TAVR, EVAR Vascular Closure Device May Eliminate Need for Surgical Cut-Down

Due to the increasing number of transcatheter aortic valve replacements (TAVR) and endovascular aneurysm repair (EVAR), a new startup company has developed a transfemoral combined access and closure system to accomodate these larger sized percutaneous devices and arteriotomies. Introduced in sessions at the 2012 American College of Cardiology (ACC) and EuroPCR, the VasoStitch system is designed to reduce procedural complexity and eliminate the need for open surgical cut-downs and surgical closure of the vessel.

The company is also developing a similar transapical TAVR access and closure device to eliminate the need to sew surgical purse-string sutures at the apex of the heart prior to introducer placement. This may significanty shorten and simplify transapical valve replacement procedures.

The system uses a helical, corkscrew-shaped, barbed suturing needle that is advanced through the vessel wall and surrounding tissue prior to vessel access. Access is accomplished though the center of the suture needle coil. When the procedure is complete, a suture tail is pulled to close the vessel and activate a bioresorbable suture lock.

“At the present time, surgical means of arterial or cardiac access-and-closure for large-diameter, catheter-based interventions such as TAVI adds about 60 minutes to an already lengthy and elaborate procedure. As a result, a device that can duplicate the current ‘gold standard’ of surgical access and repair — but in a quicker and simpler, nonsurgical procedure — will surely stimulate the adoption of large-diameter cardiovascular and endovascular therapies, as well as improve the efficiency of patient management,” said David W. J. Smith, president and CEO of Danville, Calif.-based VasoStitch. “We are moving quickly toward our first-in-human milestone.”

For more information: www.vasostitch.com


Related Content

News | Endovascular Aortic Repair

June 19, 2024 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

Home June 19, 2024
Home
News | Endovascular Aortic Repair

October 30, 2023 — -egnite, Inc., a leading cardiovascular digital health company, announced today that novel research ...

Home October 30, 2023
Home
News | Endovascular Aortic Repair

December 5, 2022 — Imagen Technologies, Inc. announced the U.S. Food and Drug Administration's 510(k) clearance of the ...

Home December 05, 2022
Home
News | Endovascular Aortic Repair

October 26, 2022 — Thousands of people have new hope for treatment of thoracic aortic arch disease and University ...

Home October 26, 2022
Home
News | Endovascular Aortic Repair

March 22, 2022 – A retrospective evaluation of 600 fenestrated-branched endovascular aortic repairs for the treatment of ...

Home March 22, 2022
Home
News | Endovascular Aortic Repair

February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of ...

Home February 18, 2022
Home
News | Endovascular Aortic Repair

May 12, 2021 — Preliminary results of a clinical trial, presented today at the AATS 101st Annual Meeting, showed that a ...

Home May 12, 2021
Home
News | Endovascular Aortic Repair

February 23, 2021 — Medtronic has voluntarily issued a global recall of unused Medtronic Valiant Navion thoracic stent ...

Home February 23, 2021
Home
News | Endovascular Aortic Repair

January 31, 2020 – The Society for Vascular Surgery (SVS) and Society of Thoracic Surgeons (STS) released new reporting ...

Home January 31, 2020
Home
News | Endovascular Aortic Repair

January 29, 2020 – The presence of a blood clot on the wall of the aorta in people with abdominal aortic aneurysms (AAA) ...

Home January 29, 2020
Home
Subscribe Now